Pregabalin Not Effective for Cancer-induced Bone Pain

Pregabalin is not effective for cancer-induced bone pain compared with placebo in patients receiving radiotherapy, a study published in the Journal of Clinical Oncology has shown.1

Radiotherapy is the gold standard for the treatment of cancer-induced bone pain, which impacts one-third of patients with cancer. However, previous research has indicated that pregabalin may be useful for treatment cancer-induced bone pain, as well. Therefore, researchers sought to compare pregabalin with placebo in conjunction with radiotherapy.

For the multicenter, double-blind study, researchers enrolled 233 patients with radiologically proven bone metastases who were scheduled to receive radiotherapy and had pain scores between 4 and 10 on a pain scale. The most common types of cancer were prostate, breast, and lung. Patients were randomly assigned 1:1 to receive increasing doses of pregabalin over 4 weeks or placebo.

Results showed that 38.8% of patients in the pregabalin group achieved a treatment response, defined as a reduction of 2 or more points in worst pain by week 4 with a stable or reduced opioid dose, compared with 40.2% of patients in the placebo arm (adjusted OR, 1.07; 95% CI: 0.63-1.81; P = .816).

Researchers found no significant differences in average pain, pain interference, or quality of life between the 2 treatment arms; however, there were significant differences in mood (P = .031) and breakthrough pain duration (P = .037).

The investigators note that the role of pregabalin in cancer-induced bone pain with a clinical neuropathic pain component remains unknown.


1. Fallon M, Hoskin PJ, Colvin LA, et al. Randomized double-blind trial of pregabalin versus placebo in conjunction with palliative radiotherapy for cancer-induced bone pain [published online ahead of print on December 7, 2015]. J Clin Oncol. doi: 10.1200/JCO.2015.63.8221.

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs